PSA Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients
In a cohort of 1898 patients treated with a uniform external-beam radiation therapy treatment approach for prostate cancer, prostate-specific antigen (PSA) fluctuations were carefully evaluated to determine their impact on long-term survival outcomes. Multivariate analysis demonstrated that the occurrence of a PSA bounce in the follow-up period predicted for reduced PSA recurrences, decreased incidence of distant metastases, and improved cause-specific and overall survival outcomes.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Paul B. Romesser, Xin Pei, Weiji Shi, Zhigang Zhang, Marisa Kollmeier, Sean M. McBride, Michael J. Zelefsky Tags: Clinical Investigation Source Type: research
More News: Adenocarcinoma | Biology | Cancer | Cancer & Oncology | External Beam Therapy | Physics | Prostate Cancer | Radiation Therapy | Radiology